Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ETON
#2569
Eton Pharmaceutcials, Inc. Common Stock
16.9
9
-0.93%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.93%
Monatliche Änderung
+13.04%
6 month change
-2.80%
Jahresänderung
+13.12%
Vorheriger Schlusskurs
17.1
5
Open
16.9
9
Bid
Ask
Low
16.9
9
High
16.9
9
Volumen
47
Märkte
Aktien
Gesundheitswesen
ETON
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
24.41 M
24.63 M
25.46 M
25.69 M
26.82 M
—
Valuation ratios
Enterprise value
177.14 M
91.24 M
57.27 M
96.52 M
342.27 M
1.58 B
Price to earnings ratio
—
—
-8.06
-125.76
-90.22
-339.82
Price to sales ratio
—
—
3.42
3.72
8.84
30.62
Price to cash flow ratio
—
—
15.07
17.27
355.96
475.94
Price to book ratio
—
—
5.56
7.61
14.12
28.72
Enterprise value to EBITDA ratio
-6.6
-696.49
-6.99
-400.5
-1 000.8
-657.49
Profitability ratios
Return on assets %
1.06
0.07
0.36
0.03
0.05
0.05
Return on equity %
1.79
0.11
0.69
0.06
0.16
0.23
Return on invested capital %
4 389.56
101.21
413.57
79.28
35.72
3.64
Gross margin %
633.33
87.99
67.38
66.56
60.01
210.63
Operating margin %
69.52 K
6.85
38.87
3.77
6.66
2.44
EBITDA margin %
-68.82 K
-0.6
-38.56
-0.76
-0.88
40.09
Net margin %
71.72 K
8.95
42.45
2.96
9.8
25.7
Liquidity ratios
Quick ratio
6.18
5.06
3.01
1.6
1.29
5.13
Current ratio
6.51
5.18
3.1
1.65
2.06
7.43
Inventory turnover
0.35
1.58
12.53
14.42
1.93
2.21
Asset turnover
0
0.81
0.81
1.11
0.72
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.19
0.22
0
0.39
1.28
Long term debt to total equity ratio
0.42
0.3
0.41
0
1.22
4.78
Per share metrics
Operating cash flow per share
—
—
0.19
0.27
0.04
0.79
EBIT per share
—
—
-0.33
-0.05
-0.1
-0.1
EBITDA per share
—
—
-0.33
-0.01
-0.01
0.23
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
0.65
0.83
0.58
3.55
Net current asset value per share
—
—
0.8
1.05
1.58
8.66
Tangible book value per share
—
—
0.33
0.42
-0.4
-1.41
Working capital per share
—
—
0.54
0.41
0.81
3.87
Book value per share
—
—
0.52
0.6
0.94
3.6
Nachrichten
FDA-Zulassung für DESMODA: Eton Pharmaceuticals zielt auf Markt für Diabetes insipidus
DESMODA oral solution receives FDA approval for diabetes insipidus
Lizenz-Deal für Medikament beflügelt Eton Pharmaceuticals-Aktie
Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug
Eton Pharmaceuticals lizenziert Wirkstoffkandidaten für extrem seltene Krankheit
Eton Pharmaceuticals licenses ultra-rare disease treatment candidate
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals: EPS verfehlt Schätzungen um 0,07 $ - Umsatz besser als erwartet
Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold